Skip to main content

Moderna says vaccine booster looks promising against COVID-19 variants

Moderna will report first-quarter earnings on Thursday, which will show revenues from sales of its COVID-19 vaccine, two days after Pfizer said it made $3.5 billion from its vaccine over the first three months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.